Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-02-28
2006-02-28
Meller, Michael (Department: 1655)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
07005416
ABSTRACT:
A pharmaceutical composition comprising synergistically effective amounts of cefpirome and dalfopristine/quinupristine combination. A method of treating a patient comprising the administration of synergistically effective amounts of cefpirome and a dalfopristine/quinupristine combination. Kits comprising synergistically effective amounts of cefpirome and a dalfopristine/quinupristine combination are also disclosed.
REFERENCES:
patent: 5631378 (1997-05-01), Urawa et al.
patent: 5686441 (1997-11-01), Maiti et al.
patent: 5994338 (1999-11-01), Bounine et al.
patent: 6187746 (2001-02-01), Conrath et al.
patent: 6465428 (2002-10-01), Feger et al.
patent: WO 98/22107 (1998-05-01), None
Feger Celine
Moreillon Philippe
Vouillamoz Jacques
Day Jones
Jones Pharma Incorporated
Meller Michael
LandOfFree
Dalfopristine/quinupristine combinations with cefpirome does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dalfopristine/quinupristine combinations with cefpirome, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dalfopristine/quinupristine combinations with cefpirome will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3625199